The DOI matches its Crossref record.
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
Abstract
The subunit composition and pharmacological regulation of rat neuronal nicotinic cholinergic receptors were assessed. Specific immunoprecipitation was determined in solubilized rat brain homogenates using [3H]cytisine, a high affinity agonist at nicotinic receptors, in conjunction with polyclonal antisera generated against nonhomologous domains of the various subunits comprising this receptor class. In all brain regions tested, only antisera generated against the alpha 4 and beta 2 subunits were able to immunoprecipitate specifically receptors labeled by [3H]cytisine. Thus, these sera were further characterized in order to validate and optimize their use in the immunoprecipitation protocol. Preincubation of solubilized receptors from rat forebrain with antisera generated against the alpha 2, alpha 3, alpha 5, beta 3, or beta 4 subunits did not decrease the amount of precipitable alpha 4 or beta 2 subunit. On the other hand, when either anti-alpha 4 or anti-beta 2 serum was used to immunoprecipitate solubilized receptors from rat forebrain, the supernatants contained little if any remaining receptors that could be specifically precipitated by either antibody. Because these antisera do not cross-react, the data indicate that alpha 4 and beta 2 subunits are associated with each other in at least one neuronal nicotinic receptor subtype that has high affinity for agonists. Moreover, these results imply that all alpha 4 subunits that are labeled by [3H]cystisine are coupled to beta 2 subunits. We also present evidence that the alpha 4/beta 2 subtype characterized in this report is significantly increased in the cortex of rats chronically treated with nicotine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, nicotine induced increases in nAChR, termed “upregulation”, are conferred by a specific microdomain that is in the β2-subunit 34 and thus this upregulation is confined to nAChR that contain the β2-subunit4, 19, 31, 35-38.”
From β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking (2009) · cites this paper as [19]
In the citing paper
“Immunoprecipitation with subunit-selective antibodies and studies in genetic knockout models demonstrate that chronic administration of nicotine increases predominantly the ␣42 subtype of nAChRs in rodent brain (Flores et al., 1992;Mao et al., 2008;Moretti et al., 2010;Marks et al., 2011)”
From Chronic Sazetidine-A at Behaviorally Active Doses Does Not Increase Nicotinic Cholinergic Receptors in Rodent Brain (2012) · cites this paper as Flores et al., 1992
Citations
Cited by
Sorted by citations
Items 201–300 of 880
Hancock, D. B., Reginsson, G. W., Gaddis, N. C., Chen, X., Saccone, N. L., Lutz, S. M., Qaiser, B., Sherva, R., Steinberg, S., Zink, F., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.149 · Cited by 85
Grillner, P., & Svensson, T. H. (2000) · Synapse · doi:10.1002/1098-2396(200010)38:1 · Cited by 75
Nicotinic Cholinergic Receptors in the Rat Cerebellum: Multiple Heteromeric Subtypes
Turner, J. R., & Kellar, K. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2112-05.2005 · Cited by 89
Fu, Y.-T., Matta, S. G., James, T. J., & Sharp, B. M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37341-0 · Cited by 92
Development of ligands for in vivo imaging of cerebral nicotinic receptors
Sihver, W., Nordberg, A. K., Långström, B., Mukhin, A. G., Koren, A. O., Kimes, A. S., & London, E. D. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00209-6 · Cited by 86
Formation of Oligomers Containing the β3 and β4 Subunits of the Rat Nicotinic Receptor
Forsayeth, J., & Kobrin, E. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01531.1997 · Cited by 85
Up-regulation of Nicotinic Receptors by Nicotine Varies with Receptor Subtype
Walsh, H., Govind, A. P., Mastro, R., Hoda, J. C., Bertrand, D., Vallejo, Y., & Green, W. N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m703432200 · Cited by 87
Slotkin, T. A., Bodwell, B. E., Levin, E. D., & Seidler, F. J. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.11005 · Cited by 87
Abdulla, F. A., Gray, J. A., Sinden, J. D., Bradbury, E. J., Calaminici, M., Lippiello, P. M., & Wonnacott, S. (1996) · Psychopharmacology · doi:10.1007/bf02247437 · Cited by 85
Neuronal and astrocyte expression of nicotinic receptor subunit β4 in the adult mouse brain
Gahring, L. C., Persiyanov, K., & Rogers, S. W. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10942 · Cited by 86
Quik, M., Vailati, S., Bordia, T., Kulak, J. M., Fan, H., McIntosh, J. M., Clementi, F., & Gotti, C. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.006015 · Cited by 86
Stauderman, K. A., Mahaffy, L. S., Akong, M., Veliçelebi, G., Chavez-Noriega, L. E., Crona, J. H., Johnson, E. C., Elliott, K. J., Gillespie, A., Reid, R. T., et al. (1998) · PubMed · doi:10.7270/q28g8j7q · Cited by 86
Nicotinic Acetylcholine Receptors in Alzheimer's Disease
Wevers, A., & Schröder, H. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-14-503 · Cited by 84
Receptor-Mediated Tobacco Toxicity
Arredondo, J., Chernyavsky, A. I., Marubio, L. M., Beaudet, A. L., Jolkovsky, D. L., Pinkerton, K. E., & Grando, S. A. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62281-x · Cited by 84
Gahring, L. C., Persiyanov, K., Dunn, D. M., Weiss, R. B., Meyer, E. L., & Rogers, S. W. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10943 · Cited by 84
Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors
Decker, M. W., Anderson, D. J., Brioni, J. D., Donnelly‐Roberts, D. L., Kang, C. H., O'Neill, A. B., Piattoni-Kaplan, M., Swanson, S. T., & Sullivan, J. P. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00191-m · Cited by 84
Nicotine-evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes
Reuben, M., & Clarke, P. B. S. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00147-1 · Cited by 84
The Molecular Biology of Neuronal Nicotinic Acetylcholine Receptors
Boyd, R. T. (1997) · Critical Reviews in Toxicology · doi:10.3109/10408449709089897 · Cited by 84
Nguyen, H. N., Rasmussen, B. A., & Perry, D. C. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02482.x · Cited by 83
Garduño, J., Galindo-Charles, L., Jiménez-Rodríguez, J., Galarraga, E., Tapia, D., Mihailescu, S., & Hernandez-Lopez, S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0941-12.2012 · Cited by 83
Nakauchi, S., Brennan, R. J., Boulter, J., & Sumikawa, K. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05513.x · Cited by 84
Meyer, E. M., Tay, E. T., Zoltewicz, J. A., Meyers, C., King, M. A., Papke, R. L., & de Fiebre, C. M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37338-0 · Cited by 83
Subunit-Dependent Modulation of Neuronal Nicotinic Receptors by Zinc
Hsiao, B., Dweck, D., & Luetje, C. W. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01848.2001 · Cited by 83
Graphical analysis of 2‐[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain
Chefer, S. I., London, E. D., Koren, A. O., Pavlova, O. A., Kurian, V., Kimes, A. S., Horti, A. G., & Mukhin, A. G. (2003) · Synapse · doi:10.1002/syn.10180 · Cited by 82
Reduced nicotinic receptor-mediated antinociception following in vivo antisense knock-down in rat
Bitner, R. S., Nikkel, A. L., Curzon, P., Donnelly‐Roberts, D. L., Puttfarcken, P. S., Namovic, M. T., Jacobs, I. C., Meyer, M. D., & Decker, M. W. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02442-2 · Cited by 82
Happe, H. K., Peters, J. L., Bergman, D. A., & Murrin, L. C. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90484-7 · Cited by 82
Turner, J. R., Castellano, L. M., & Blendy, J. A. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq206 · Cited by 78
Nicotine and endogenous opioids: neurochemical and pharmacological evidence
Hadjiconstantinou, M., & Neff, N. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.010 · Cited by 81
Heterogeneity of Nicotinic Cholinergic Receptors in Rat Superior Cervical and Nodose Ganglia
Mao, D., Yasuda, R. P., Fan, H., Wolfe, B. B., & Kellar, K. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027458 · Cited by 81
Self-citationMarks, M. J., Rowell, P. P., Cao, J., Grady, S. R., McCallum, S. E., & Collins, A. C. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.009 · Cited by 81
Regulation of α4β2 Nicotinic Receptor Desensitization by Calcium and Protein Kinase C
Fenster, C. P., Beckman, M. L., Parker, J. C., Sheffield, E. B., Whitworth, T. L., Quick, M. W., & Lester, R. A. J. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12167-0 · Cited by 81
Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning
Portugal, G. S., Wilkinson, D. S., Turner, J. R., Blendy, J. A., & Gould, T. J. (2012) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2012.04.003 · Cited by 79
Sallette, J., Bohler, S., Benoit, P., Soudant, M., Pons, S., Le Novère, N., Changeux, J.-P., & Corringer, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308260200 · Cited by 80
Sex difference in up-regulation of nicotinic acetylcholine receptors in rat brain
Koylu, E., Demirgören, S., London, E. D., & Pöǧün, S. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00665-6 · Cited by 104
Cortical Hypoexcitability in Chronic Smokers? A Transcranial Magnetic Stimulation Study
Lang, N., Hasan, A., Sueske, E., Paulus, W., & Nitsche, M. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301645 · Cited by 80
Kroes, R. A., Burgdorf, J. S., Otto, N. J., Panksepp, J., & Moskal, J. R. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.03.022 · Cited by 81
Neurological disorders caused by inherited ion-channel mutations
Kullmann, D. M., & Hanna, M. G. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00071-6 · Cited by 80
Clarke, P. B. S. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62383-3 · Cited by 78
El-Bizri, H., & Clarke, P. B. S. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14749.x · Cited by 79
Marks, M. J., Whiteaker, P., Calcaterra, J., Stitzel, J. A., Bullock, A. E., Grady, S. R., Picciotto, M. R., Changeux, J.-P., & Collins, A. C. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38240-0 · Cited by 79
Xiu, J., Nordberg, A. K., Zhang, J., & Guan, Z.-Z. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.04.023 · Cited by 82
Sullivan, J. P., Donnelly‐Roberts, D. L., Briggs, C. A., Anderson, D. J., Gopalakrishnan, M., Xue, I. C., Piattoni-Kaplan, M., Molinari, E. J., Campbell, J. E., McKenna, D. G., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37014-4 · Cited by 79
Nicotine exploits a COPI-mediated process for chaperone-mediated up-regulation of its receptors
Henderson, B. J., Srinivasan, R., Nichols, W. A., Dilworth, C. N., Gutierrez, D. F., Mackey, E. D. W., McKinney, S., Drenan, R. M., Richards, C. I., & Lester, H. A. (2014) · Journal of General Physiology · doi:10.1085/jgp.201311102 · Cited by 78
Analgesic and Toxic Effects of Neonicotinoid Insecticides in Mice
Tomizawa, M., Cowan, A., & Casida, J. E. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9292 · Cited by 78
Cooper, S. T., Harkness, P. C., Baker, E. R., & Millar, N. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27145 · Cited by 78
Bannon, A. W., Decker, M. W., Curzon, P., Buckley, M. J., Kim, D. J. B., Radek, R. J., Lynch, J. K., Wasicak, J. T., Lin, N., Arnold, W. H., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37423-3 · Cited by 78
Fowler, C. D., Tuesta, L. M., & Kenny, P. J. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3235-1 · Cited by 79
Nicotinic acetylcholine receptor redux: Discovery of accessories opens therapeutic vistas
Matta, J. A., Gu, S., Davini, W. B., & Bredt, D. S. (2021) · Science · doi:10.1126/science.abg6539 · Cited by 75
Positive and Negative Effects of Alcohol and Nicotine and Their Interactions: A Mechanistic Review
Hurley, L. L., Taylor, R. E., & Tizabi, Y. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9275-6 · Cited by 83
Gozzi, A., Schwarz, A. J., Reese, T., Bertani, S., Crestan, V., & Bifone, A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300955 · Cited by 77
Darsow, T., Booker, T. K., Piña-Crespo, J. C., & Heinemann, S. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501157200 · Cited by 76
Effect of nicotine, lobeline, and mecamylamine on sensory gating in the rat
Curzon, P., Kim, D. J. B., & Decker, M. W. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90237-2 · Cited by 76
Waggoner, L. E., Dickinson, K., Poole, D. S., Tabuse, Y., Miwa, J., & Schafer, W. R. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08802.2000 · Cited by 76
Martin, E. J., Panickar, K. S., King, M. A., Deyrup, M. D., Hunter, B. E., Wang, G., & Meyer, E. M. (1994) · Drug Development Research · doi:10.1002/ddr.430310208 · Cited by 76
Pandey, S. C., Roy, A., Xu, T., & Mittal, N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00309.x · Cited by 75
Whiteaker, P., Sharples, C. G. V., & Wonnacott, S. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13263-4 · Cited by 152
Wu, J., Liu, Q., Yu, K., Hu, J., Kuo, Y., Segerberg, M., John, P. A. S., & Lukas, R. J. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.114645 · Cited by 74
Harkness, P. C., & Millar, N. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10172.2002 · Cited by 74
Tumkosit, P., Kuryatov, A., Luo, J., & Lindstrom, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027326 · Cited by 73
Chavez-Noriega, L. E., Gillespie, A. J., Stauderman, K. A., Crona, J. H., Claeps, B. O., Elliott, K. J., Reid, R. T., Rao, T. S., Veliçelebi, G., Harpold, M. M., et al. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00134-9 · Cited by 73
Acetylcholine Receptors: Too Many Channels, Too Few Functions
Sivilotti, L. G., & Colquhoun, D. (1995) · Science · doi:10.1126/science.7569892 · Cited by 73
Davis, J. A., & Gould, T. J. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0624-8 · Cited by 72
Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors
Hogg, R. C., & Bertrand, D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.010 · Cited by 72
Wevers, A., Jeske, A., Lobron, C., Birtsch, C., Heinemann, S., Maelicke, A., Schröder, R., & Schröder, H. C. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90286-0 · Cited by 72
Vizi, E. S., Sershen, H. W., BALLA, A., Mike, Á., Windisch, K., Jurányi, Z., & Lajtha, Á. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17466.x · Cited by 72
McCallum, S. E., Collins, A. C., Paylor, R. E., & Marks, M. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0076-6 · Cited by 71
Portugal, G. S., & Gould, T. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.05.006 · Cited by 73
Eilers, H., Schaeffer, E., Bickler, P. E., & Forsayeth, J. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.6.1105 · Cited by 71
Marks, M. J., McClure-Begley, T. D., Whiteaker, P., Salminen, O., Brown, R. W. B., Cooper, J., Collins, A. C., & Lindstrom, J. M. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.178236 · Cited by 70
Depressive Characteristics of FSL Rats
Tizabi, Y., Rezvani, A. H., Russell, L. T., Tyler, K. Y., & Overstreet, D. H. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00236-7 · Cited by 70
Miller, D. K., Crooks, P. A., & Dwoskin, L. P. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00140-4 · Cited by 71
Tani, Y., Saito, K., Imoto, M., & Ohno, T. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00314-8 · Cited by 69
Duncan, J., Randall, L. L., Belliveau, R., Trachtenberg, F., Randall, B., Habbe, D., Mandell, F., Welty, T. K., Iyasu, S., & Kinney, H. C. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00093.x · Cited by 75
Gotti, C., Moretti, M., Meinerz, N. M., Clementi, F., Gaimarri, A., Collins, A. C., & Marks, M. J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045203 · Cited by 68
Acute and chronic effects of nornicotine on locomotor activity in rats: altered response to nicotine
Dwoskin, L. P., Crooks, P. A., Teng, L., Green, T. A., & Bardo, M. T. (1999) · Psychopharmacology · doi:10.1007/s002130051079 · Cited by 68
Imaging of Cholinergic and Monoaminergic Neurochemical Changes in Neurodegenerative Disorders
Bohnen, N. I., & Frey, K. A. (2007) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0083-6 · Cited by 67
Gao, B.-X., Hierl, M., Clarkin, K., Juan, T., Nguyen, H. Q., van der Valk, M., Deng, H. X., Guo, W., Lehto, S. G., Matson, D. J., et al. (2010) · Pain · doi:10.1016/j.pain.2010.01.007 · Cited by 67
Cholinergic Modulation of Spindle Bursts in the Neonatal Rat Visual Cortex In Vivo
Hanganu, I. L., Staiger, J. F., Ben-Ari, Y., & Khazipov, R. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5233-06.2007 · Cited by 67
Yates, S. L., Bencheri, M., Fluhler, E. N., & Lippiello, P. M. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02100-0 · Cited by 65
Levin, E. D., Timofeeva, O. A., Yang, L., Petro, A. E., Ryde, I. T., Wrench, N., Seidler, F. J., & Slotkin, T. A. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.11.007 · Cited by 66
Rushforth, S. L., Allison, C., Wonnacott, S., & Shoaib, M. C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.01.022 · Cited by 65
Ligand Binding and Activation of Rat Nicotinic α4β2 Receptors Stably Expressed in HEK293 Cells
Sabey, K., Paradiso, K. G., Zhang, J., & Steinbach, J. H. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.1.58 · Cited by 66
Gene-Gene Interactions Among CHRNA4, CHRNB2, BDNF, and NTRK2 in Nicotine Dependence
Li, M. D., Lou, X., Chen, G., Ma, J. Z., & Elston, R. C. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.026 · Cited by 64
Nicotinic AChR in Subclassified Capsaicin-Sensitive and -Insensitive Nociceptors of the Rat DRG
Rau, K. K., Johnson, R. D., & Cooper, B. Y. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00591.2004 · Cited by 64
LaLone, C. A., Villeneuve, D. L., Wu-Smart, J. Y., Milsk, R. Y., Sappington, K. G., Garber, K. V., Housenger, J., & Ankley, G. T. (2017) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2017.01.113 · Cited by 67
Salminen, O., Whiteaker, P., Grady, S. R., Collins, A. C., McIntosh, J. M., & Marks, M. J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.011 · Cited by 63
Grady, S. R., Grun, E. U., Marks, M. J., & Collins, A. C. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36799-0 · Cited by 65
Greenwood, P. M., Fossella, J., & Parasuraman, R. (2005) · Journal of Cognitive Neuroscience · doi:10.1162/089892905774597281 · Cited by 64
Crunelle, C. L., Miller, M. L., Booij, J., & van den Brink, W. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.11.001 · Cited by 66
Cognitive Deficits in Schizophrenia: Focus on Neuronal Nicotinic Acetylcholine Receptors and Smoking
Ochoa, E. L. M., & Lasalde‐Dominicci, J. A. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9149-x · Cited by 64
Nishizaki, T., Nomura, T., Matsuoka, T., Enikolopov, G., & Sumikawa, K. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00117-5 · Cited by 64
The role of the cholinergic system in the development of the human cerebellum
COURT, J. A., Perry, E. K., Spurden, D., Griffiths, M., Kerwin, J. M., Morris, C. M., Johnson, M., Oakley, A. E., Birdsall, N. J. M., Clementi, F., et al. (1995) · Developmental Brain Research · doi:10.1016/0165-3806(96)83496-1 · Cited by 65
Kadir, A., Darreh‐Shori, T., Almkvist, O., Wall, A. E., Långström, B., & Nordberg, A. K. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0725-z · Cited by 63
Papke, R. L., Webster, J. C., Lippiello, P. M., Bencherif, M., & Francis, M. M. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750204.x · Cited by 63
Ghosh, S. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970407)380:2 · Cited by 53
Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice.
Raybuck, J. D., Portugal, G. S., Lerman, C., & Gould, T. J. (2008) · Behavioral Neuroscience · doi:10.1037/a0012601 · Cited by 62
Nicotine addiction: insights from recent animal studies
Mathieu-Kia, A.-M., Kellogg, S. H., Butelman, E. R., & Kreek, M. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1096-0 · Cited by 63
Pandya, A. A., & Yakel, J. L. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.05.018 · Cited by 65
Eaton, J. B., Lucero, L. M., Stratton, H. J., Chang, Y., Cooper, J. F., Lindstrom, J. M., Lukas, R. J., & Whiteaker, P. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208389 · Cited by 63
Addiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61
Metadata
- Authors
- Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J.
- Affiliations
- Georgetown University Medical Center (US)
- University of Colorado Denver (US)
- Georgetown University (US)
- ORCID
- Kellar, K J
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 1992-01
- Volume
- 41
- Issue
- 1
- Pages
- 31-37
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2116249462
- Cited by
- 880
- References
- 0
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 7 · 2021: 7 · 2020: 7 · 2019: 10 · 2018: 7 · 2017: 9 · 2016: 18 · 2015: 25 · 2014: 25 · 2013: 22 · 2012: 21
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Funders
- National Institutes of Health (5r01ag009884-05, 5r01da006486-10, 5r01ns011549-24)
- National Institute on Aging (AG 09884)
- National Institute on Drug Abuse (DA-06486)
- National Institute of Neurological Disorders and Stroke (NS11549)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, receptor subunit composition, chronic nicotine treatment, receptor up-regulation, rat cortex, forebrain, neuronal nicotinic receptors
- MeSH terms
- Quinolizidine Alkaloids, Alkaloids, Animals, Antibodies, Azocines, Brain, Kinetics, Male, Nicotine, Precipitin Tests, Quinolizines, Rats, Inbred Strains, Receptors, Nicotinic, Time Factors, Tritium, Up-Regulation, Macromolecular Substances, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review